Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News The Spectranetics Corporation SPNC

Healthcare Medical Devices
"The Spectranetics Corp manufactures and sells single-use medical devices which are used to cross, prepare, and treat arterial blockages in the legs and heart and to remove pacemaker and defibrillator cardiac leads."

Recent & Breaking News (NDAQ:SPNC)

Spectranetics to Present at the Canaccord Genuity Growth Conference

GlobeNewswire July 29, 2015

Spectranetics to Present at the Canaccord Genuity Growth Conference

GlobeNewswire July 29, 2015

Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology

GlobeNewswire July 29, 2015

Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology

GlobeNewswire July 29, 2015

Investigation of The Spectranetics Corporation Announced by The Law Offices of Howard G. Smith

Business Wire July 27, 2015

INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims Against Spectranetics Corp. on Behalf of Investors

Business Wire July 24, 2015

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation of Spectranetics Corp. and Its Board of Directors in Connection with Possible Violations of Federal Securities Laws

Business Wire July 24, 2015

Spectranetics Reports Second Quarter Financial Results

GlobeNewswire July 23, 2015

Spectranetics to Hold 2015 Second Quarter Financial Results Conference Call on July 23, 2015

GlobeNewswire July 9, 2015

Federal Court in California Awards AngioScore $20 Million Plus Disgorgement in Breach of Fiduciary Duty Case

GlobeNewswire July 2, 2015

Spectranetics Receives FDA 510(k) Clearance for Larger Diameter AngioSculpt(R) Scoring Balloon Enabling Entry Into New Markets

GlobeNewswire June 24, 2015

EXCITE ISR Landmark Study Proves Durability at 12-Months, Findings Validate Safety and Superiority of Laser Atherectomy With PTA vs. PTA Alone; Data Presented at NCVH 2015

GlobeNewswire May 27, 2015

Spectranetics to Participate in Upcoming Investor Conferences

GlobeNewswire April 30, 2015

Spectranetics Achieves First Quarter 2015 Revenue of $57.4 Million

GlobeNewswire April 23, 2015

Spectranetics Accelerates Investment in Stellarex(TM) Drug- Coated Balloon Platform for Treatment of Below the Knee (BTK) Peripheral Vascular Disease

GlobeNewswire April 23, 2015

Spectranetics to Hold 2015 First Quarter Financial Results Conference Call on April 23

GlobeNewswire April 13, 2015

Spectranetics Announces Chief Financial Officer Transition

GlobeNewswire March 18, 2015

Spectranetics Appoints Todd C. Schermerhorn as Director

GlobeNewswire March 12, 2015

Spectranetics Achieves Fourth Quarter 2014 Revenue of $63.0 Million

GlobeNewswire February 19, 2015

Spectranetics to Hold 2014 Fourth Quarter Financial Results Conference Call on February 19

GlobeNewswire February 5, 2015